Search by Drug Name or NDC

    NDC 53746-0735-30 Felbamate 600 mg/1 Details

    Felbamate 600 mg/1

    Felbamate is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals of New York LLC. The primary component is FELBAMATE.

    Product Information

    NDC 53746-0735
    Product ID 53746-735_a979682b-bb8c-4ba1-8373-3170967a2125
    Associated GPIs
    GCN Sequence Number 020042
    GCN Sequence Number Description felbamate TABLET 600 MG ORAL
    HIC3 H4B
    HIC3 Description ANTICONVULSANTS
    GCN 38022
    HICL Sequence Number 008186
    HICL Sequence Number Description FELBAMATE
    Brand/Generic Generic
    Proprietary Name Felbamate
    Proprietary Name Suffix n/a
    Non-Proprietary Name Felbamate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 600
    Active Ingredient Units mg/1
    Substance Name FELBAMATE
    Labeler Name Amneal Pharmaceuticals of New York LLC
    Pharmaceutical Class Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA201680
    Listing Certified Through 2024-12-31

    Package

    NDC 53746-0735-30 (53746073530)

    NDC Package Code 53746-735-30
    Billing NDC 53746073530
    Package 30 TABLET in 1 BOTTLE (53746-735-30)
    Marketing Start Date 2022-08-10
    NDC Exclude Flag N
    Pricing Information N/A